financetom
HSIC
financetom
/
Healthcare
/
HSIC
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Henry Schein, Inc.HSIC
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide.

It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services.

This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins.

The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners.

This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services.

Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

Latest News >
--Pure Storage Guides For Q2 Revenue of $755 Million, vs CIQ Analyst Consensus of $752 Million; FY 2025 Revenue Seen at $3.1 Billion, vs Consensus of $3.1 Billion
--Pure Storage Guides For Q2 Revenue of $755 Million, vs CIQ Analyst Consensus of $752 Million; FY 2025 Revenue Seen at $3.1 Billion, vs Consensus of $3.1 Billion
May 29, 2024
04:11 PM EDT, 05/29/2024 (MT Newswires) -- Price: 62.20, Change: -0.81, Percent Change: -1.28 ...
--C3.ai Guides For Q1 Revenue of $84-$89 Million, vs CIQ Analyst Consensus of $86 Million; FY 2025 Revenue Seen at $370-$395 Million, vs Consensus of $368 Million
--C3.ai Guides For Q1 Revenue of $84-$89 Million, vs CIQ Analyst Consensus of $86 Million; FY 2025 Revenue Seen at $370-$395 Million, vs Consensus of $368 Million
May 29, 2024
04:09 PM EDT, 05/29/2024 (MT Newswires) -- Price: 27.10, Change: +3.18, Percent Change: +13.29 ...
Insulet Insider Sold Shares Worth $596,970, According to a Recent SEC Filing
Insulet Insider Sold Shares Worth $596,970, According to a Recent SEC Filing
May 29, 2024
04:11 PM EDT, 05/29/2024 (MT Newswires) -- Timothy J Scannell, Director, on May 28, 2024, sold 3,300 shares in Insulet ( PODD ) for $596,970. Following the Form 4 filing with the SEC, Scannell has control over a total of 42,586 shares of the company, with 42,586 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1145197/000112760224016771/xslF345X03/form4.xml ...
Salesforce forecasts second-quarter revenue below estimates
Salesforce forecasts second-quarter revenue below estimates
May 29, 2024
(Reuters) - Salesforce ( CRM ) forecast second-quarter revenue below Wall Street expectations on Wednesday, on weak client spending on its cloud and enterprise business products in an uncertain economy, sending its shares down 9% in extended trading. The company forecast revenue between $9.20 billion and $9.25 billion compared with estimates of $9.37 billion, according to LSEG data. Salesforce's (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved